{"id":"bnt162b2-bivalent-wt-omi-ba-1","rwe":[],"tags":[],"safety":{"drugInteractions":[{"drug":"Warfarin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Aspirin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Pain medications","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Anticoagulants","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Antiplatelets","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Corticosteroids","action":"Monitor","effect":"Increased risk of immunosuppression"},{"drug":"Live vaccines","action":"Avoid","effect":"Interference with vaccine efficacy"},{"drug":"Immunosuppressants","action":"Monitor","effect":"Decreased immune response"}],"commonSideEffects":[{"effect":"Injection site pain (PAIN)","drugRate":"82.7%","organSystem":"General disorders","placeboRate":"","totalAtRisk":104,"totalAffected":86,"trialsReporting":1},{"effect":"Fatigue (FATIGUE)","drugRate":"73.1%","organSystem":"General disorders","placeboRate":"","totalAtRisk":104,"totalAffected":76,"trialsReporting":1},{"effect":"Headache (HEADACHE)","drugRate":"52.9%","organSystem":"Nervous system disorders","placeboRate":"","totalAtRisk":104,"totalAffected":55,"trialsReporting":1},{"effect":"Myalgia (MUSCLE PAIN)","drugRate":"35.6%","organSystem":"Musculoskeletal and connective tissue disorders","placeboRate":"","totalAtRisk":104,"totalAffected":37,"trialsReporting":1},{"effect":"Chills (CHILLS)","drugRate":"21.2%","organSystem":"General disorders","placeboRate":"","totalAtRisk":104,"totalAffected":22,"trialsReporting":1},{"effect":"Arthralgia (JOINT PAIN)","drugRate":"18.3%","organSystem":"Musculoskeletal and connective tissue disorders","placeboRate":"","totalAtRisk":104,"totalAffected":19,"trialsReporting":1},{"effect":"Diarrhoea (DIARRHEA)","drugRate":"14.4%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":104,"totalAffected":15,"trialsReporting":1},{"effect":"Injection site swelling (SWELLING)","drugRate":"10.6%","organSystem":"General disorders","placeboRate":"","totalAtRisk":104,"totalAffected":11,"trialsReporting":1},{"effect":"Injection site erythema (REDNESS)","drugRate":"5.8%","organSystem":"General disorders","placeboRate":"","totalAtRisk":104,"totalAffected":6,"trialsReporting":1},{"effect":"COVID-19","drugRate":"2.9%","organSystem":"Infections and infestations","placeboRate":"","totalAtRisk":104,"totalAffected":3,"trialsReporting":1},{"effect":"Pyrexia (FEVER)","drugRate":"1.9%","organSystem":"General disorders","placeboRate":"","totalAtRisk":104,"totalAffected":2,"trialsReporting":1},{"effect":"Vomiting (VOMITING)","drugRate":"1.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":104,"totalAffected":1,"trialsReporting":1},{"effect":"Back pain","drugRate":"0.0%","organSystem":"Musculoskeletal and connective tissue disorders","placeboRate":"","totalAtRisk":104,"totalAffected":0,"trialsReporting":1},{"effect":"Bell's palsy","drugRate":"0.0%","organSystem":"Nervous system disorders","placeboRate":"","totalAtRisk":104,"totalAffected":0,"trialsReporting":1},{"effect":"Blood pressure increased","drugRate":"0.0%","organSystem":"Investigations","placeboRate":"","totalAtRisk":104,"totalAffected":0,"trialsReporting":1},{"effect":"Diarrhoea","drugRate":"0.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":104,"totalAffected":0,"trialsReporting":1},{"effect":"Ear pain","drugRate":"0.0%","organSystem":"Ear and labyrinth disorders","placeboRate":"","totalAtRisk":104,"totalAffected":0,"trialsReporting":1},{"effect":"Fatigue","drugRate":"0.0%","organSystem":"General disorders","placeboRate":"","totalAtRisk":104,"totalAffected":0,"trialsReporting":1},{"effect":"Headache","drugRate":"0.0%","organSystem":"Nervous system disorders","placeboRate":"","totalAtRisk":104,"totalAffected":0,"trialsReporting":1},{"effect":"Hypercholesterolaemia","drugRate":"0.0%","organSystem":"Metabolism and nutrition disorders","placeboRate":"","totalAtRisk":104,"totalAffected":0,"trialsReporting":1},{"effect":"Injection site pain","drugRate":"0.0%","organSystem":"General disorders","placeboRate":"","totalAtRisk":104,"totalAffected":0,"trialsReporting":1},{"effect":"Joint abscess","drugRate":"0.0%","organSystem":"Infections and infestations","placeboRate":"","totalAtRisk":104,"totalAffected":0,"trialsReporting":1},{"effect":"Lymphadenopathy","drugRate":"0.0%","organSystem":"Blood and lymphatic system disorders","placeboRate":"","totalAtRisk":104,"totalAffected":0,"trialsReporting":1},{"effect":"Myalgia","drugRate":"0.0%","organSystem":"Musculoskeletal and connective tissue disorders","placeboRate":"","totalAtRisk":104,"totalAffected":0,"trialsReporting":1},{"effect":"Otitis media","drugRate":"0.0%","organSystem":"Infections and infestations","placeboRate":"","totalAtRisk":104,"totalAffected":0,"trialsReporting":1},{"effect":"Sinusitis","drugRate":"0.0%","organSystem":"Infections and infestations","placeboRate":"","totalAtRisk":104,"totalAffected":0,"trialsReporting":1},{"effect":"Thermal burn","drugRate":"0.0%","organSystem":"Injury, poisoning and procedural complications","placeboRate":"","totalAtRisk":104,"totalAffected":0,"trialsReporting":1},{"effect":"Upper respiratory tract infection","drugRate":"0.0%","organSystem":"Infections and infestations","placeboRate":"","totalAtRisk":104,"totalAffected":0,"trialsReporting":1},{"effect":"Urinary tract infection","drugRate":"0.0%","organSystem":"Infections and infestations","placeboRate":"","totalAtRisk":104,"totalAffected":0,"trialsReporting":1},{"effect":"Vomiting","drugRate":"0.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":104,"totalAffected":0,"trialsReporting":1},{"effect":"Vulvovaginal mycotic infection","drugRate":"0.0%","organSystem":"Infections and infestations","placeboRate":"","totalAtRisk":104,"totalAffected":0,"trialsReporting":1},{"effect":"Vulvovaginal pruritus","drugRate":"0.0%","organSystem":"Reproductive system and breast disorders","placeboRate":"","totalAtRisk":104,"totalAffected":0,"trialsReporting":1}],"contraindications":["have any allergies","have had myocarditis (inflammation of the heart muscle) or pericarditis (inflammation of the lining outside the heart)","have a fever","have a bleeding disorder or are on a blood thinner","are immunocompromised or are on a medicine that affects the immune system","are pregnant, plan to become pregnant, or are breastfeeding","have received another COVID-19 vaccine","have ever fainted in association with an injection","have had a severe allergic reaction after a previous dose of COMIRNATY or the Pfizer-BioNTech COVID-19 Vaccine or any ingredient in these vaccines"],"specialPopulations":{"Pregnancy":"No information available","Geriatric use":"No information available","Paediatric use":"No information available","Renal impairment":"No information available","Hepatic impairment":"No information available"},"seriousAdverseEvents":[{"event":"Acute kidney injury","detail":"Renal and urinary disorders. 1 trial(s).","severity":"serious","incidence":"1.0%"},{"event":"Gastroenteritis","detail":"Infections and infestations. 1 trial(s).","severity":"serious","incidence":"1.0%"},{"event":"Normocytic anaemia","detail":"Blood and lymphatic system disorders. 1 trial(s).","severity":"serious","incidence":"1.0%"},{"event":"Adenocarcinoma pancreas","detail":"Neoplasms benign, malignant and unspecified (incl cysts and polyps). 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Alcohol poisoning","detail":"Injury, poisoning and procedural complications. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Arrhythmia","detail":"Cardiac disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Back pain","detail":"Musculoskeletal and connective tissue disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Biliary colic","detail":"Hepatobiliary disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Diverticulitis","detail":"Infections and infestations. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Enterocolitis infectious","detail":"Infections and infestations. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Hypoglycaemia","detail":"Metabolism and nutrition disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Hypokalaemia","detail":"Metabolism and nutrition disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Hypotension","detail":"Vascular disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Left ventricular failure","detail":"Cardiac disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Leukaemia","detail":"Neoplasms benign, malignant and unspecified (incl cysts and polyps). 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Pancreatitis acute","detail":"Gastrointestinal disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Post procedural infection","detail":"Infections and infestations. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Prostate cancer","detail":"Neoplasms benign, malignant and unspecified (incl cysts and polyps). 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Small intestinal obstruction","detail":"Gastrointestinal disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Suicidal ideation","detail":"Psychiatric disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Syncope","detail":"Nervous system disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Testicular germ cell cancer","detail":"Neoplasms benign, malignant and unspecified (incl cysts and polyps). 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Type 2 diabetes mellitus","detail":"Metabolism and nutrition disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Urinary tract obstruction","detail":"Renal and urinary disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"}]},"trials":[],"aliases":[],"company":"Pfizer","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=bnt162b2-bivalent-wt-omi-ba-1","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-19T23:39:51.338389+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-19T23:39:58.933589+00:00"},"regulatory.eu":{"url":"","method":"api_direct","source":"European Medicines Agency","rawText":"","confidence":1,"sourceType":"ema_api","retrievedAt":"2026-04-19T23:39:51.360053+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=bnt162b2-bivalent-wt-omi-ba-1","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-19T23:39:59.776922+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5791340/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-19T23:40:00.864688+00:00"},"safety.commonSideEffects":{"url":"","method":"deterministic","source":"ClinicalTrials.gov (1 trials)","rawText":"","confidence":1,"sourceType":"ctgov_results","retrievedAt":"2026-04-20T08:32:20.408920+00:00"}},"allNames":"bnt162b2 bivalent (wt/omi ba.1)","offLabel":[],"timeline":[],"aiSummary":"BNT162b2 Bivalent (WT/OMI BA.1) is a marketed COVID-19 vaccine developed by Pfizer Inc. It prevents COVID-19 in individuals 12 years and older, 5 years and older, and 6 months through 4 years of age. The vaccine has generated $21.2B in revenue. Its mechanism is not specified. The vaccine has one clinical trial and no publications. It is a marketed vaccine, indicating its clinical differentiation and commercial significance. There are no pipeline developments mentioned.","brandName":"BNT162b2 Bivalent (WT/OMI BA.1)","ecosystem":[],"isGeneric":true,"mechanism":{"target":"SARS-CoV-2 spike protein","novelty":"best-in-class","modality":"mRNA","drugClass":"mRNA vaccine","explanation":"","oneSentence":"","technicalDetail":"The BNT162b2 Bivalent (WT/OMI BA.1) vaccine uses a lipid nanoparticle-formulated, nucleoside-modified mRNA to encode the SARS-CoV-2 spike protein. This mRNA is designed to be taken up by cells, where it is translated into the spike protein. The immune system recognizes the spike protein as foreign and mounts an immune response, providing protection against COVID-19."},"_companyIR":{"url":"https://www.pfizer.com/investors","revenueRefs":[],"pipelineRefs":[]},"commercial":{"annualCostUS":"$80,000/yr","genericStatus":"Generic — off-patent","currentRevenue":"$21.2B","peakSalesEstimate":"$21.2B"},"references":[{"id":1,"url":"https://clinicaltrials.gov/search?intr=bnt162b2-bivalent-wt-omi-ba-1","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=bnt162b2-bivalent-wt-omi-ba-1","fields":["publications"],"source":"PubMed/NCBI"},{"id":3,"url":"https://www.ebi.ac.uk/chembl/","fields":["molecular"],"source":"ChEMBL (EMBL-EBI)"},{"id":4,"url":"https://www.ema.europa.eu/","fields":["regulatoryStatus"],"source":"European Medicines Agency (EMA)"},{"id":5,"url":"https://list.essentialmeds.org/","fields":["regulatoryStatus"],"source":"WHO Essential Medicines List"}],"_tgaChecked":true,"_validation":{"fieldsValidated":4,"lastValidatedAt":"2026-04-20T08:32:21.750243+00:00","fieldsConflicting":0,"overallConfidence":0.95},"_whoChecked":true,"biosimilars":[],"competitors":[{"name":"BNT162b2 (30 μg)","company":"Pfizer/BioNTech","advantage":"Serves as the baseline comparator in the study, providing a standard for evaluating the performance of the BA.1-adapted vaccines."},{"name":"Monovalent BA.1 (30 μg and 60 μg)","company":"Pfizer/BioNTech","advantage":"Shows superior neutralizing activity against the BA.1 variant compared to BNT162b2 (30 μg)."},{"name":"Bivalent BA.1 (30 μg and 60 μg)","company":"Pfizer/BioNTech","advantage":"Demonstrates non-inferiority to BNT162b2 (30 μg) in neutralizing activity against the ancestral strain and shows higher neutralizing titers against BA.4, BA.5, and BA.2.75 strains."}],"genericName":"bnt162b2-bivalent-wt-omi-ba-1","indications":{"approved":[{"name":"Prevention of COVID-19 in individuals 12 years of age and older","regulator":"FDA"},{"name":"Prevention of COVID-19 in individuals 5 years of age and older","regulator":"FDA"},{"name":"Prevention of COVID-19 in individuals 6 months through 4 years of age","regulator":"FDA"}],"offLabel":[],"pipeline":[]},"_mhraChecked":true,"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT05472038","phase":"PHASE2, PHASE3","title":"A Study to Learn About New COVID-19 RNA Vaccine Candidates in COVID-19 Vaccine-Experienced Healthy Individuals","status":"COMPLETED","sponsor":"BioNTech SE","startDate":"2022-07-26","conditions":"SARS-CoV-2 Infection, COVID-19","enrollment":1453}],"_emaApprovals":[{"date":"","name":"BNT162b2 Bivalent (WT/OMI BA.1)","status":"Authorised","regulator":"EMA"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"molecularData":{"oral":false,"chemblId":"CHEMBL5791340","moleculeType":null,"molecularWeight":"319.43"},"_patentsChecked":true,"_warningLetters":[{"date":"03/28/2023","subject":"11/07/2022\tTodos Medical Ltd aka Todos Medical USA Inc\tCenter for Food Safety and Applied Nutrition"},{"date":"03/27/2026","subject":"Feedback form"}],"crossReferences":{"chemblId":"CHEMBL5791340"},"formularyStatus":[],"_offLabelChecked":true,"developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Immunology"],"biosimilarFilings":[],"recentPublications":[],"_drugWebsiteChecked":true,"_healthCanadaChecked":true,"companionDiagnostics":[],"_genericFilersChecked":true,"structuredTrialResults":[{"hr":"2.91","nctId":"NCT05472038","phase":"PHASE2, PHASE3","pValue":"","ciLower":"2.45","ciUpper":"3.44","endpoint":"GMR of Omicron (BA.4/BA.5)- NT of BNT162b2 Bivalent [WT/ OMI BA.4/ BA.5] 30 mcg Cohort 2 (Group 4)/ Cohort 3 (Group 2) Combined in C4591044 Compared to NT of BNT162b2 30 mcg in C4591031 [NCT04955626]- 1 Month After Vaccination Among Participants >55 Years","enrollment":1453}],"genericManufacturerList":[],"phase":"marketed","status":"active","companyName":"Pfizer","companyId":"pfizer","modality":"mRNA","firstApprovalDate":"","enrichmentLevel":5,"visitCount":9,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"EU","regulator":"EMA","status":"pending","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"GB","regulator":"MHRA","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"pricingByCountry":[{"country_code":"US","currency":"USD","price_amount":"80000.00","price_per":"year","price_type":"annual_list","annual_cost_usd":null,"reimbursement_status":null}],"trialStats":{"total":1,"withResults":1},"validation":{"fieldsValidated":4,"lastValidatedAt":"2026-04-20T08:32:21.750243+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}